Advanced Biomed Inc. Disposes of Hong Kong Subsidiary, Transfers Intellectual Property for $23,000

martes, 30 de diciembre de 2025, 10:19 am ET1 min de lectura
ADVB--

Advanced Biomed Inc. has announced the disposal of its Hong Kong subsidiary for $23,000. The company plans to centralize clinical trials through its Taiwan subsidiary, citing evolving regulatory requirements and a desire to accelerate product development and commercialization. The sale includes all intellectual property owned by the Hong Kong subsidiary, including that of its Shanghai subsidiary.

Advanced Biomed Inc. Disposes of Hong Kong Subsidiary, Transfers Intellectual Property for $23,000

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios